title: [Conservative therapy of erectile dysfunction].
abstract: The erectile dysfunction (ED) with a prevalence of 19.2% and a steep age-related increase up to 53.4% in men over 70 years is a common sexual disorder. Especially after market launch of the phosphodiesterase 5 inhibitors the possibility of an easy-to-use and well-tolerated therapy is available. In case of nonresponse, vasoactive substances can be applied in different forms. In case of an additional hypogonadism, testosterone substitution is indicated. Simultaneously the causes of ED should always be treated, including a change of lifestyle with elimination of exogenous noxa. The use of mechanic tools as single or combination therapy can lead to improved erection. This article provides a critical overview of the latest conservative therapy options, it explains previous unsuccessful therapeutic trials and gives an outlook into potential ED therapy concepts of the future.
authors.affiliation: Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, 81377, München, Deutschland, matthias.trottmann@med.uni-muenchen.de.
authors.forename: M
authors.initials: M
authors.lastname: Trottmann
authors.forename: J
authors.initials: J
authors.lastname: Marcon
authors.forename: S
authors.initials: S
authors.lastname: Pompe
authors.forename: D
authors.initials: D
authors.lastname: Strobach
authors.forename: A J
authors.initials: AJ
authors.lastname: Becker
authors.forename: C G
authors.initials: CG
authors.lastname: Stief
mesh_terms: D003131:Combined Modality Therapy / Q000295:instrumentation / Q000379:methods; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000628:therapy*; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D015917:Penile Prosthesis; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage*; D013739:Testosterone / Q000008:administration & dosage*; D016896:Treatment Outcome; D064804:Urological Agents / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D064804:Urological Agents; D014665:Vasodilator Agents; D013739:Testosterone